XML 75 R54.htm IDEA: XBRL DOCUMENT v3.25.3
Segment and Enterprise Reporting (Tables)
9 Months Ended
Sep. 27, 2025
Segment Reporting [Abstract]  
Schedule of Selected Information for Healthcare Segment
Selected information for the healthcare segment is presented below for each of the three and nine months ended September 27, 2025 and September 28, 2024:
Three Months Ended
Nine Months Ended
(in millions)September 27,
2025
September 28,
2024
September 27,
2025
September 28,
2024
Revenues:
Healthcare$371.2 $343.3 $1,112.5 $1,026.8 
Other(1)
0.3 — 1.9 — 
Total revenues$371.5 $343.3 $1,114.4 $1,026.8 
Cost of goods:
Healthcare
$140.4 $127.3 $414.9 $384.5 
Other(1)
0.5 3.9 1.6 16.3 
Total costs of goods sold$140.9 $131.2 $416.5 $400.8 
Gross profit:
Segment gross profit$230.8 $215.9 $697.7 $642.2 
Acquired asset amortization(1)(2)
(0.3)(0.5)(0.9)(1.5)
Business transition and related costs(1)(3)
0.1 (5.2)1.2 (12.3)
Acquisitions, integrations, divestitures, and
related costs(1)(4)
— — — (0.1)
Other(1)
— 1.9 (0.1)(2.3)
Total gross profit$230.6 $212.1 $697.9 $626.0 
____________________________
(1)     Management excludes certain revenues and expenses from segment gross profit. Management considers these excluded amounts to be non-recurring or non-operational and as such, are excluded from segment gross profit as this enables management to better understand operational results.
(2)     Acquired asset amortization is a non-GAAP financial measure. These transactions represent amortization expense in connection with business or assets acquisitions associated with acquired intangible assets including, but not limited to customer relationships, intellectual property, trade names and non-competition agreements.
(3)     Business transition and related costs is a non-GAAP financial measure. These transactions represent gains, losses, and other related costs associated with business transition plans. These items may include but are not limited to severance, relocation, consulting, leasehold exit costs, asset impairment, and other related costs to rationalize our operational footprint and optimize business results.
(4)     Acquisitions, integrations, divestitures, and related costs are a non-GAAP financial measure. These transactions represent gains, losses, and other related costs associated with acquisitions, integrations, investments, divestitures, assets impairments, and in-process research and development.